Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/j.1582-4934.2009.00987.x http://scihub22266oqcxt.onion/10.1111/j.1582-4934.2009.00987.x C4373358!4373358!20015202     free     free     free       J+Cell+Mol+Med 2011 ; 15 (8): 1645-87 Nephropedia Template TP {{tp|p=20015202|t=2011. Growth factors in ischemic stroke |pdf=|usr=}}{{20015202}} gab.com Text Growth factors in ischemic stroke JO: J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=20015202 #FOAvip Data from pre-clinical and clinical studies provide evidence that colony-stimulating factors (CSFs) and other growth factors (GFs) can improve stroke outcome by reducing stroke damage through their anti-apoptotic and anti-inflammatory effects, and by promoting angiogenesis and neurogenesis. This review provides a critical and up-to-date literature review on CSF use in stroke. We searched for experimental and clinical studies on haemopoietic GFs such as granulocyte CSF, erythropoietin, granulocyte-macrophage colony-stimulating factor, stem cell factor (SCF), vascular endothelial GF, stromal cell-derived factor-1? and SCF in ischemic stroke. We also considered studies on insulin-like growth factor-1 and neurotrophins. Despite promising results from animal models, the lack of data in human beings hampers efficacy assessments of GFs on stroke outcome. We provide a comprehensive and critical view of the present knowledge about GFs and stroke, and an overview of ongoing and future prospects. Twit Text FOAVip Growth factors in ischemic stroke ????J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=20015202 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=20015202 #FOAvip English Wikipedia <ref>{{Cite pmid|20015202}}</ref> Growth factors in ischemic stroke #MMPMID20015202 Lanfranconi S; Locatelli F; Corti S; Candelise L; Comi GP; Baron PL; Strazzer S; Bresolin N; Bersano A J Cell Mol Med 2011[Aug]; 15 (8): 1645-87 PMID20015202show ga Data from pre-clinical and clinical studies provide evidence that colony-stimulating factors (CSFs) and other growth factors (GFs) can improve stroke outcome by reducing stroke damage through their anti-apoptotic and anti-inflammatory effects, and by promoting angiogenesis and neurogenesis. This review provides a critical and up-to-date literature review on CSF use in stroke. We searched for experimental and clinical studies on haemopoietic GFs such as granulocyte CSF, erythropoietin, granulocyte-macrophage colony-stimulating factor, stem cell factor (SCF), vascular endothelial GF, stromal cell-derived factor-1? and SCF in ischemic stroke. We also considered studies on insulin-like growth factor-1 and neurotrophins. Despite promising results from animal models, the lack of data in human beings hampers efficacy assessments of GFs on stroke outcome. We provide a comprehensive and critical view of the present knowledge about GFs and stroke, and an overview of ongoing and future prospects. äGrowth factors in ischemic stroke (epmc).pdf DeepDyve Pubget Overpricing